Psychedelic Therapy Shows No Advantage Over Antidepressants Under Fair Comparison, Study Finds In A Nutshell A major new ...

Findings from a randomized and blinded clinical trial investigating repeated ketamine infusions for treating depression have revealed no extra benefit from ketamine when added to standard care for ...

Mindbio Therapeutics Corp. (TSE:MBIO) has released an update. MindBio Therapeutics Corp. has completed the final milestone of its Phase 2A microdosing depression clinical trial, demonstrating a ...

Neuropsychiatric drug development is rife with clinical trial failures, but Alto Neuroscience aims to overcome these hurdles with a precision medicine approach that matches a patient to a drug. A ...

Northwell Health is conducting a clinical trial to address treatment-resistant depression using similar technology used to treat neurological diseases like Parkinson’s in an effort to seek options for ...

There is an urgent need for new and more effective treatments for depression. The results of a recent study show that ...

Dr. Michael Verbora the medical director of Field Trip, holds a blister pack of Ketamine lozenges at the psychedelic therapy clinic in Toronto, Ontario, Canada, on August 28, 2020. (Photo by Cole ...

Researchers questioned psychedelic's true efficacy in unblinded trials ...

In a comparison of depression treatment trials, control group outcomes in trials of psilocybin were lower than those in trials of SSRIs and esketamine. This may suggest that psilocybin's ...

Learn more about a clinical trial examining a potential new treatment for depression in adult patients. Managing symptoms of depression can feel overwhelming, but you are not alone. If you experience ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A trial found ketamine infusions were no more effective ...

Rockville-based Vanda Pharmaceuticals Inc., which swung to a $2.2 million profit in its latest quarter, said it will begin late-stage clinical trials with one of its experimental drugs in the ...